-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
published Monday in the Journal of Society Science explains how adipose tissue provides energy to tumors. This opens up the possibility for the medical community to develop new anti-cancer therapies.
Researchers at the Sanford Burnham-Prebis Institute for Medical Discovery in the United States and the University of Technology in Munich, Germany, have found in animal experiments that infesting a protein called p62 in fat cells inhibits a protein called the mammalian repamycin target protein, which promotes the energy-depleting process by which prostate tumors shut down adipose tissue, absorb fatty acids and other nutrients, and accelerate growth and transfer to other parts of the body.
researchers point out that mammalian repamycin target protein inhibitors are currently used in the treatment of many cancers, and this study just explains how they work against cancer.
is not only a genetic or cellular disease, but also a systemic process in which tumors and metabolic organs communicate with each other to continuously take nutrients, said Maria Diaz-Meko of the Sanford Burnham-Prebis Institute for Medical Discovery, which was involved in the study. The study will help the medical community find better anti-cancer treatments. (Source: Xinhua News Agency Zhou Zhou)
